Expression and structure of interleukin 4 receptor (IL-4R) complex in human invasive pituitary adenomas

Neuroscience Letters

Volumn 417, Issue 1, 2007, Pages 30-35

  Chen, Lukui ^a   Liu, Yunsheng ^b   Hou, Yonghong ^b   Kato, Yoko ^c   Sano, Hirotoshi ^c   Kanno, Tetsuo ^c  

^a XIAMEN UNIVERSITY   (China)

^b CENTRAL SOUTH UNIVERSITY   (China)

^c FUJITA HEALTH UNIVERSITY   (Japan)

Author keywords

Immunotoxin therapy; Interleukin; Pituitary adenoma; Receptor; Tumor invasion

Indexed keywords

IMMUNOTOXIN; INTERLEUKIN 13 RECEPTOR ALPHA1; INTERLEUKIN 2 RECEPTOR GAMMA; INTERLEUKIN 4 RECEPTOR ALPHA; RNA;

ARTICLE; COMPLEX FORMATION; CONTROLLED STUDY; GLIOBLASTOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPOPHYSIS ADENOMA; IMMUNOFLUORESCENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSCRIPTION REGULATION;

ADENOMA; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; IMMUNOTHERAPY; INTERLEUKIN RECEPTOR COMMON GAMMA SUBUNIT; INTERLEUKIN-13 RECEPTOR ALPHA1 SUBUNIT; NEOPLASM INVASIVENESS; PITUITARY NEOPLASMS; PREDICTIVE VALUE OF TESTS; PROTEIN SUBUNITS; RECEPTORS, INTERLEUKIN-4; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR MARKERS, BIOLOGICAL;

EID: 34047151189     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2007.02.070     Document Type: Article

References (34)

1. Beseth B.D., Cameron R.B., Leland P., You L., Varricchio F., Kreitman R.J., Maki R.A., Jablons D.M., Husain S.R., and Puri R.K. Interleukin-4 receptor cytotoxin as therapy for human malignant pleural mesothelioma xenografts. Ann. Thorac. Surg. 78 (2004) 436-443
2. Garland L., Gitlitz B., Ebbinghaus S., Pan H., de Haan H., Puri R.K., Von Hoff D., and Figlin R. Phase I trial of intravenous IL-4 Pseudomonas exotoxin protein (NBI-3001) in patients with advanced solid tumors that express the IL-4 receptor. J. Immunother. 28 (2005) 376-381
3. Husain S.R., Kreitman R.J., Pastan L., and Puri R.K. Interleukin-4 receptor-directed cytotoxin therapy of AIDS-associated Kaposi's sarcoma tumors in xenograft model. Nat. Med. 5 (1999) 817-822
4. Joshi B.H., Leland P., Asher A., Prayson R.A., Varricchio F., and Puri R.K. In situ expression of interleukin-4 (IL-4) receptors in human brain tumors and cytotoxicity of a recombinant IL-4 cytotoxin in primary glioblastoma cell cultures. Cancer Res. 61 (2001) 8058-8061
5. Joshi B.H., Plautz G.E., and Puri R.K. Interleukin-13 receptor alpha chain: a novel tumor-associated transmembrane protein in primary explants of human malignant gliomas. Cancer Res. 60 (2000) 1168-1172
6. Joshi B.H., Leland P., Silber J., Kreitman R.J., Pastan I., Berger M., and Puri R.K. IL-4 receptors on human medulloblastoma tumours serve as a sensitive target for a circular permuted IL-4-Pseudomonas exotoxin fusion protein. Br. J. Cancer 86 (2002) 285-291
7. Kawakami M., Kawakami K., and Puri R.K. Interleukin-4-Pseudomonas exotoxin chimeric fusion protein for malignant glioma therapy [review]. J. Neurooncol. 65 (2003) 15-25
8. Kioi M., Takahashi S., Kawakami M., Kawakami K., Kreitman R.J., and Puri R.K. Expression and targeting of interleukin-4 receptor for primary and advanced ovarian cancer therapy. Cancer Res. 65 (2005) 8388-8396
9. Kurpad S.N., Zhao X.G., Wikstrand C.J., Batra S.K., McLendon R.E., and Bigner D.D. Tumor-antigen in astrocytic glioma. Glia 15 (1995) 244-256
10. Laws Jr. E.R., Scheithauer B.W., Carpenter S., Randall R.V., and Abboud C.F. The pathogenesis of acromegaly: clinical and immunocytochemical analysis in 75 patients. J. Neurosurg. 63 (1985) 35-38
11. Martell L.A., Agrawal A., Ross D.A., and Muraszko K.M. Efficacy of transferrin receptor-targeted immunotoxins in brain tumor cell lines and pediatric brain tumors. Cancer Res. 53 (1993) 1348-1353
12. Milanese C., Richardson N.E., and Reinherz E.L. Identification of a T helper cell-derived lymphokine that activates resting T lymphocytes. Science 231 (1986) 1118-1122
13. Milanese C., Silisiano R.F., Schmidt R.E., Ritz J., Richardson N.E., and Reinherz E.L. A lymphokine that activates the cytolytic program of both cytotoxic T lymphocyte and natural killer clones. J. Exp. Med. 163 (1986) 1583-1588
14. Morrison B.W., and Leder P. A receptor binding domain of mouse interleukin-4 defined by a solid-phase binding assay and in vitro mutagenesis. J. Biol. Chem. 267 (1992) 11957-11963
15. Murata T., Noguchi P.D., and Puri R.K. Receptors for interleukin (IL)-4 do not associate with the common gamma chain, and IL-4 induces phosphorylation of JAK2 tyrosine kinase in human colon carcinoma cells. J. Biol. Chem. 270 (1995) 30829-30836
16. Murata T., Obiri N.I., and Puri R.K. Structure of and signal transduction through interleukin-4 and interleukin-13 receptors [review]. Int. J. Mol. Med. 1 (1998) 551-557
17. Murata T., Taguchi J., and Puri R.K. Interleukin-13 receptor alpha' but not alpha chain: a functional component of interleukin-4 receptors. Blood 91 (1998) 3884-3891
18. Obiri N.I., Hillman G.G., Haas G.P., Sud S., and Puri R.K. Expression of high affinity interleukin-4 receptors on human renal carcinoma cells and inhibition of tumor cell growth in vitro by interleukin-4. J. Clin. Invest. 91 (1993) 88-93
19. Obiri N.I., Siegel J., Varricchio F., and Puri R.K. Expression of high affinity interleukin-4 receptors on human melanoma, ovarian and breast carcinoma cells. Clin. Exp. Immunol. 95 (1994) 148-155
20. Paul W.E. Interleukin-4: a prototypic immunoregulatory lymphokine. Blood 77 (1991) 1859-1870
21. Plaut M., Peirce J.H., Watson C.J., Hanley-Hyde J., Nordan R.P., and Paul W.E. Mast cell lines produce lymphokines in response to cross-linkage of Fc epsilon RI or to calcium ionophores. Nature 339 (1989) 64-67
22. Puri R.K. Cytotoxins directed at interleukin-4 receptors as therapy for human brain tumors. Meth. Mol. Biol. 166 (2001) 155-176
23. Puri R.K. Development of a recombinant interleukin-4-Pseudomonas exotoxin for therapy of glioblastoma. Toxicol. Pathol. 27 (1999) 53-57
24. Puri R.K. Structure and function of interleukin-4 and its receptor. In: Kurzrock R., and Talpaz M. (Eds). Cytokines: Interleukins and Their Receptors (1995), Kluwer Academic Publishers, Norwell 143-186
25. Puri R.K., Hoon D.S., Leland P., Snoy P., Rand R.W., Pastan I., and Kreitman R.J. Preclinical development of a recombinant toxin containing circularly permuted interleukin 4 and truncated Pseudomonas exotoxin for therapy of malignant astrocytoma. Cancer Res. 56 (1996) 5631-5637
26. Puri R.K., Leland P., Kreitman R., and Pastan I. Human neurological cancer cells express interleukin-4 (IL-4) receptors which are targets for the toxic effects of IL4-Pseudomonas exotoxin chimeric protein. Int. J. Cancer 58 (1994) 574-581
27. Puri R.K., and Siegel J.P. Interleukin-4 and cancer therapy. Cancer Invest. 11 (1993) 473-486
28. Rand W., Kreitman R.J., Patronas N., Varricchio F., Pastan I., and Puri R.K. Intratumoral administration of recombinant circularly permuted interleukin-4-Pseudomonas exotoxin in patients with high grade glioma. Clin. Cancer Res. (Adv. Brief) 6 (2000) 2157-2165
29. Randall R.V., Laws Jr. E.R., Abboud C.F., Ebersold M.J., Kao P.C., and Scheithauer B.W. Transsphenoidal microsurgical treatment of prolactin-producing pituitary adenomas: results in 100 patients. Mayo Clin. Proc. 58 (1983) 108-121
30. Schleimer R.P., Derse C.P., Friedman B., Gillis S., Plaut M., Lichtenstein L.M., and MacGlashan Jr. D.W. Regulation of human basophil mediator release by cytokines. Part I. Interaction with anti-inflammatory steroids. J. Immunol. 143 (1989) 1310-1317
31. Selman W.R., Laws Jr. E.R., Scheithauer B.W., and Carpenter S.M. The occurrence of dural invasion in pituitary adenomas. J. Neurosurg. 64 (1986) 402-407
32. Varricchio F., Obiri N.I., Haas G.P., and Puri R.K. Immunostaining of interleukin-4 receptor on human renal cell carcinoma. Lymphokine Cytokine Res. 12 (1993) 465-469
33. Wilson C.B. A decade of pituitary microsurgery: the Herbert Olivecrona Lecture. J. Neurosurg. 61 (1984) 814-833
34. Zurawski G., and de Vries J.E. Interleukin 13, an interleukin 4 like cytokine that acts on monocytes and B cells, but not on T cells. Immunol. Today 15 (1994) 19-26